Gene therapy breakthrough trial targets hepatitis b virus
Disease control
Recruiting now
This first-in-human study is testing a new gene therapy called PBGENE-HBV for people with chronic hepatitis B. The trial will enroll 45 adults who are already taking medication to control their hepatitis B virus. Researchers will test different doses to check safety and see if th…
Phase: PHASE1 • Sponsor: Precision BioSciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC